Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report.
Streetwise Reports | May 14, 2020 |

From Cystic Fibrosis to COVID-19: A Medical Solution Like No Other

(Image via Dymedso Inc.) Airway clearance therapy has been a cornerstone of treatments aimed at minimizing the devastating effects of airway obstruction, infection, and inflammation caused by a buildup of mucus in lung conditions … but finding a non-invasive solutio...
Stockhouse Editorial | December 8, 2020 |

Buzz on the Bullboards: Some Stocks to be Thankful For

(Image via Ivanhoe Mines Ltd.) As November draws to a close, what are investors thankful for? Even if the US Thanksgiving is something you don’t celebrate, major stock markets hovering around record highs recently could be some cause for celebration....
Stockhouse Editorial | November 24, 2021 |

Will New Coronavirus Kill Global Economy and Humanity, Making Precious Metals Shine?

The World Health Organization has declared the coronavirus outbreak a global health emergency. What does it mean for the global economy and the gold market? Will Coronavirus Kill Us All? So it looks like not the recently feared nuclear war with the North Korea or Iran, ...
Arkadiusz Sieron | February 3, 2020 |

Here’s Why You Shouldn’t Panic Over China’s Factory Slowdown

Chinese manufacturing activity slumped to a record low in February as the coronavirus outbreak temporarily shuttered plants and factories and travel restrictions impacted the supply of labor. The official government purchasing manager’s index (PMI) fell to...
Frank Holmes | March 5, 2020 |

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 ...

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 Treatment Shares of Bellerophon Therapeutics reached a new 52-week high price after the firm reported that the FDA granted emergency expanded access for its INOpulse®...
Streetwise Reports | March 23, 2020 |

MediciNova Shares Rise 40% on Plans to Initiate COVID-19 ARDS Clinical Trial

Shares of MediciNova traded higher after the company reported that it plans to initiate a clinical study of MN-166 (ibudilast) for COVID-19 acute respiratory distress syndrome. Biopharmaceutical company MediciNova, Inc. yesterday announced that "it will ...
Streetwise Reports | April 13, 2020 |

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report. In an April 9 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Mesoblast Lt...
Streetwise Reports | April 16, 2020 |

Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease

Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report. In an April 4 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals Inc.'s (INO:NASDA...
Streetwise Reports | April 11, 2019 |

Novavax Shares Rise 9% Upon Initiating Phase 1/2 COVID-19 Vaccine Clinical Trial

Novavax shares traded higher after the company reported it enrolled the first participants in its Phase 1 clinical study of NVX CoV2373. Novavax Inc. (NVAX:NASDAQ) , which focuses its efforts on developing next-generation vaccines to address infectious diseases, ye...
Streetwise Reports | May 27, 2020 |
1 2 3 4 5 6 7 8 9 10 ...